Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) COO Mukul Jain sold 25,000 shares of the business’s stock in a transaction on Friday, June 4th. The stock was sold at an average price of $2.70, for a total transaction of $67,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Mukul Jain also recently made the following trade(s):
- On Monday, May 17th, Mukul Jain sold 100,000 shares of Senseonics stock. The shares were sold at an average price of $1.94, for a total transaction of $194,000.00.
NYSEAMERICAN:SENS opened at $3.62 on Friday. Senseonics Holdings, Inc. has a one year low of $0.35 and a one year high of $5.56. The business’s 50-day simple moving average is $0.48. The company has a market capitalization of $1.55 billion, a price-to-earnings ratio of -2.97 and a beta of 0.41.
A number of research firms have issued reports on SENS. Zacks Investment Research upgraded shares of Senseonics from a “sell” rating to a “hold” rating in a research report on Wednesday, March 10th. Raymond James restated an “underperform” rating on shares of Senseonics in a research report on Thursday, March 11th. Stifel Nicolaus boosted their price objective on shares of Senseonics from $1.00 to $2.50 and gave the company a “buy” rating in a research report on Friday, March 5th. They noted that the move was a valuation call. Finally, SVB Leerink cut shares of Senseonics from an “outperform” rating to a “market perform” rating and set a $3.00 price objective on the stock. in a research report on Thursday, April 1st. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $1.75.
Large investors have recently bought and sold shares of the stock. Delphi Management Partners VIII L.L.C. bought a new position in shares of Senseonics in the fourth quarter worth approximately $8,585,000. Masters Capital Management LLC lifted its stake in shares of Senseonics by 369.0% in the first quarter. Masters Capital Management LLC now owns 9,380,649 shares of the company’s stock worth $24,765,000 after buying an additional 7,380,649 shares in the last quarter. BlackRock Inc. lifted its stake in shares of Senseonics by 101.1% in the first quarter. BlackRock Inc. now owns 5,637,619 shares of the company’s stock worth $14,883,000 after buying an additional 2,834,433 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Senseonics by 97.6% in the first quarter. Geode Capital Management LLC now owns 2,365,138 shares of the company’s stock worth $6,243,000 after buying an additional 1,168,266 shares in the last quarter. Finally, Parian Global Management LP bought a new position in shares of Senseonics in the fourth quarter worth approximately $1,744,000. 16.01% of the stock is currently owned by institutional investors and hedge funds.
Senseonics Holdings, Inc, a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to 90 and 180 days.
Further Reading: What is a death cross?
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.